Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

NCT05103644 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT05103644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05103644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
Lead sponsor
Beni-Suef University
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 30, 2021
Completion date
December 30, 2024
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer